Last reviewed · How we verify
SUN-131 1.5% TDS
SUN-131 1.5% TDS is a topical sulfonamide antibiotic used to treat bacterial conjunctivitis.
SUN-131 1.5% TDS is a topical sulfonamide antibiotic used to treat bacterial conjunctivitis. Used for Bacterial conjunctivitis.
At a glance
| Generic name | SUN-131 1.5% TDS |
|---|---|
| Sponsor | Senju USA, Inc. |
| Drug class | topical sulfonamide antibiotic |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
SUN-131 1.5% TDS works by inhibiting bacterial growth and reducing inflammation in the conjunctiva. It is effective against a wide range of bacteria, including Staphylococcus aureus and Streptococcus pneumoniae.
Approved indications
- Bacterial conjunctivitis
Common side effects
- Eye irritation
Key clinical trials
- Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (PHASE3)
- Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |